BioSpace News Archive

insitro, a machine learning driven drug discovery and development company, today announced the acquisition of Haystack Sciences, a private company advancing proprietary methods to drive machine-learning enabled drug discovery.

- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, November 5 , at 4:30 p.m. ET to discuss third quarter 2020 financial results and provide a general business update.